David Z I Cherney Selected Research

Allopurinol (Remid)

10/2021

Allopurinol and Renal Outcomes in Adults With and Without Type 2 Diabetes: A Retrospective, Population-Based Cohort Study and Propensity Score Analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Z I Cherney Research Topics

Disease

76	Type 2 Diabetes Mellitus (MODY) 04/2024 - 01/2015
58	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2024 - 10/2005
39	Chronic Renal Insufficiency 01/2024 - 01/2018
30	Diabetic Nephropathies (Diabetic Nephropathy) 12/2023 - 10/2014
28	Heart Failure 04/2024 - 11/2014
26	Hyperglycemia 04/2024 - 10/2005
24	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 01/2016
20	Albuminuria 01/2024 - 01/2017
17	Kidney Diseases (Kidney Disease) 04/2024 - 08/2013
9	Body Weight (Weight, Body) 02/2024 - 03/2016
7	Myocardial Infarction 04/2024 - 09/2016
7	Stroke (Strokes) 04/2024 - 09/2016
7	Diabetes Mellitus 04/2024 - 01/2015
7	Inflammation (Inflammations) 01/2024 - 12/2013
7	Hypertension (High Blood Pressure) 01/2023 - 01/2016
6	Chronic Kidney Failure (Chronic Renal Failure) 04/2024 - 06/2006
6	Proteinuria 01/2023 - 03/2016
5	Infections 04/2024 - 09/2016
5	Acute Kidney Injury (Acute Renal Failure) 11/2023 - 09/2016
5	Hypoglycemia (Reactive Hypoglycemia) 11/2023 - 05/2014
5	Renal Insufficiency (Renal Failure) 10/2023 - 10/2020
4	Weight Loss (Weight Reduction) 12/2023 - 01/2018
3	Disease Progression 01/2024 - 01/2018
3	Obesity 12/2023 - 01/2023
3	Ketosis 11/2023 - 01/2021
3	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 11/2023 - 01/2021
3	Fibrosis (Cirrhosis) 01/2023 - 05/2016
2	Hyperkalemia 12/2023 - 11/2021
2	Atherosclerosis 11/2021 - 01/2019
2	Hypovolemia 10/2021 - 11/2019
2	Glycosuria 03/2016 - 01/2015
1	Metabolic Diseases (Metabolic Disease) 04/2024

Drug/Important Bio-Agent (IBA)

42	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 09/2010
36	Sodium-Glucose Transporter 2 InhibitorsIBA 02/2024 - 09/2016
33	SodiumIBA 04/2024 - 10/2014
28	Sodium-Glucose Transport ProteinsIBA 03/2024 - 02/2014
19	empagliflozinIBA 11/2023 - 02/2014
18	ertugliflozinIBA 10/2023 - 01/2020
17	CreatinineIBA 11/2023 - 01/2017
14	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2009
11	AlbuminsIBA 10/2023 - 01/2017
9	finerenoneIBA 12/2023 - 01/2018
8	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2024 - 06/2018
8	Inulin FDA Link 06/2019 - 02/2010
7	DiureticsIBA 02/2024 - 11/2017
7	Uric Acid (Urate)IBA 01/2022 - 08/2013
7	dapagliflozinIBA 01/2022 - 01/2018
6	SymportersIBA 04/2024 - 10/2020
6	Mineralocorticoid Receptor AntagonistsIBA 04/2024 - 01/2018
6	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 01/2024 - 01/2021
6	Insulin (Novolin)FDA Link 11/2023 - 05/2014
6	CytokinesIBA 03/2016 - 01/2011
5	omega-Chloroacetophenone (Mace)IBA 04/2024 - 01/2018
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023 - 11/2008
5	ChemokinesIBA 03/2016 - 01/2011
4	IncretinsIBA 02/2024 - 05/2016
4	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2023 - 05/2013
4	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023 - 01/2017
4	ReninIBA 01/2021 - 02/2010
3	Metformin (Glucophage)FDA LinkGeneric 02/2024 - 12/2018
3	KetonesIBA 11/2023 - 01/2022
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 07/2023 - 01/2016
3	Hemoglobins (Hemoglobin)IBA 11/2022 - 09/2016
3	DiamondIBA 01/2022 - 01/2020
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2022 - 10/2005
3	AtrasentanIBA 01/2021 - 01/2018
3	Natriuretic AgentsIBA 01/2019 - 01/2017
3	Angiotensin IIIBA 12/2018 - 07/2010
3	CanagliflozinIBA 01/2018 - 01/2017
3	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 11/2017 - 01/2017
3	aliskiren FDA Link 10/2013 - 02/2010
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2010 - 03/2008
2	Endothelin Receptor AntagonistsIBA 04/2024 - 07/2022
2	LipidsIBA 01/2024 - 11/2021
2	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2023 - 01/2021
2	semaglutideIBA 01/2023 - 11/2022
2	Insulin Glargine (Lantus)FDA Link 01/2023 - 11/2022
2	tirzepatideIBA 01/2023 - 11/2022
2	Glucagon-Like Peptide-1 ReceptorIBA 11/2022 - 11/2021
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2014
2	Cystatin CIBA 06/2019 - 01/2012
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019 - 11/2012
2	Dipeptidyl-Peptidase IV InhibitorsIBA 06/2018 - 01/2017
2	AngiotensinogenIBA 02/2017 - 08/2014
2	C-Reactive ProteinIBA 01/2016 - 11/2014
2	Chemokine CCL22IBA 11/2014 - 01/2011
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2014 - 01/2011
2	ruboxistaurinIBA 01/2012 - 01/2009
2	Enalapril FDA LinkGeneric 01/2012 - 10/2005
2	Protein Kinases (Protein Kinase)IBA 01/2012 - 01/2009
2	Celecoxib (Celebrex)FDA Link 06/2010 - 03/2008
1	SuspensionsIBA 05/2024

Therapy/Procedure

27	Therapeutics 04/2024 - 06/2006
6	Glycemic Control 01/2023 - 05/2014
3	Kidney Transplantation 04/2024 - 10/2014
3	Bariatric Surgery 02/2024 - 01/2023
2	Drug Therapy (Chemotherapy) 01/2024 - 01/2022
2	Aftercare (After-Treatment) 11/2023 - 08/2017
2	Secondary Prevention 12/2020 - 01/2016
2	Heart-Assist Devices 01/2016 - 11/2014